Hippocampal atrophy correlates with clinical features of Alzheimer diseasein African Americans

Citation
D. Sencakova et al., Hippocampal atrophy correlates with clinical features of Alzheimer diseasein African Americans, ARCH NEUROL, 58(10), 2001, pp. 1593-1597
Citations number
40
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ARCHIVES OF NEUROLOGY
ISSN journal
00039942 → ACNP
Volume
58
Issue
10
Year of publication
2001
Pages
1593 - 1597
Database
ISI
SICI code
0003-9942(200110)58:10<1593:HACWCF>2.0.ZU;2-K
Abstract
Context: Imaging measurements may aid in the characterization and diagnosis of patients with Alzheimer disease (AD). Most research studies, however, h ave been performed on predominantly white study groups despite the fact tha t there may be biological differences in AD between African American and wh ite patients. Objective: To measure hippocampal volume in African American patients with AD and to correlate these measurements with the presence of AD and neuropsy chological test performance. Design: Survey study. Setting: Academic center. Participants: Fifty-four healthy African American subjects and 32 African A merican patients with AD were studied. Hippocampal volumes were measured in all subjects from magnetic resonance images using established methods. Main Outcome Measure: Correlations were assessed between hippocampal volume and demographic variables, clinical group membership, and neuropsychologic al performance. Results: The hippocampi of patients were atrophic with respect to those of healthy subjects (P < .01). Significant direct correlations were present be tween hippocampal volumes and performance on several different neuropsychol ogical tests (r >0.5 and P < .01 for every test evaluated) when patients an d healthy subjects were combined. Conclusions: Hippocampal atrophy is a feature of AD in African Americans as it is in white subjects. The neuropsychological-hippocampal volume correla tions indicate that hippocampal volume measurements do represent a measure of the structural substrate of functional impairment in AD.